The global veterinary CRO market size was valued at USD 1.17 billion in 2025 and is projected to grow from USD 1.26 billion in 2026 to USD 2.25 billion by 2034, registering a CAGR of 7.56% during the forecast period (2026–2034). North America dominated the veterinary CRO marketwith a marketshare of 42.08% in 2025.
Veterinary CRO services provide outsourced research support for animal health companies, including clinical trials, regulatory consulting, laboratory testing, and preclinical studies for veterinary pharmaceuticals and medical devices. These services help companies accelerate product development, ensure regulatory compliance, and reduce research costs.
The veterinary CRO market demand is driven by rising investments in animal healthcare, growing pet ownership, and increasing development of advanced veterinary therapeutics. Expanding veterinary infrastructure and increasing focus on animal disease management are also contributing to veterinary CRO market growth.
Download a Free Sample To learn more about this report,
Growing Adoption of Decentralized Clinical Trials in Veterinary Research
Veterinary CROs are increasingly supporting decentralized clinical trial models that use remote monitoring, digital data collection, and virtual consultations to improve trial accessibility and efficiency. This transition enables broader participation of animal owners and veterinary clinics while reducing study timelines and operational costs. For example, CROs are integrating digital platforms for remote health tracking of companion animals during pharmaceutical trials.
Increasing Use of Real World Data for Veterinary Product Development
The growing availability of veterinary health records and real-world evidence is transforming how animal healthcare products are evaluated and developed. This transition enables CROs to analyze clinical data from veterinary practices, improving treatment validation, safety assessment, and regulatory submissions. For example, Mars Veterinary Health leverages data from millions of pets across its global clinic network and supports research initiatives such as the Mars Petcare Biobank, which tracks 20,000 dogs and cats to identify disease patterns and improve preventive care strategies.
The veterinary CRO market forecasts continued investment activity driven by rising demand for animal health research outsourcing, increasing development of veterinary pharmaceuticals and biologics, and growing adoption of advanced clinical trial and regulatory support services. In 2026, the US FDA’s Center for Veterinary Medicine (CVM) announced FY2026 grant funding for the Animal and Veterinary Innovation Centers (AVICs) program to strengthen veterinary research and innovation. The funding will support up to five cooperative grants, renewable for up to four years, focusing on areas such as aquaculture drug development, minor species therapeutics, food safety, and antimicrobial stewardship. The initiative aims to build collaborations between the FDA and academic research institutions to address regulatory challenges and accelerate the development of veterinary products.
Increasing Development of Veterinary Pharmaceuticals and Growing Pet Ownership & Companion Animal Healthcare Spending Drives Market
The rising investment in veterinary drug discovery, vaccines, and biologics increases the need for specialized CRO capabilities, driving demand for outsourced research services. Pharmaceutical and biotechnology companies are using CROs to access regulatory expertise, clinical trial management, and specialized animal testing facilities without expanding internal infrastructure. Companies such as Zoetis and Boehringer Ingelheim Animal Health collaborate with external research partners to support development and evaluation of veterinary therapeutics.
The increasing adoption of pets and rising spending on advanced companion animal healthcare are driving demand for new veterinary treatments and clinical studies. This growth encourages pharmaceutical companies to conduct more clinical trials for chronic conditions, preventive therapies, and specialty medicines, increasing reliance on veterinary CRO services. This expansion of companion animal healthcare innovation is strengthening demand for veterinary CROs and specialized trial management services.
High Regulatory Complexity and Limited Availability of Specialized Veterinary Research Infrastructure Restrain Market Expansion
Strict regulatory requirements for veterinary clinical research increase operational complexity for CROs, as studies require compliance with different animal safety, efficacy, and approval guidelines across regions. These regulatory variations increase documentation needs, trial timelines, and operational costs. As CROs must maintain specialized regulatory expertise and quality systems, smaller service providers face challenges in scaling operations, which limits faster adoption of outsourced veterinary research services.
The shortage of advanced veterinary research facilities, species-specific testing centers, and skilled professionals limits the capacity of CROs to manage complex clinical studies. Establishing specialized animal research infrastructure requires significant capital investment and operational expertise. These infrastructure limitations increase service costs and reduce accessibility for pharmaceutical companies, particularly in emerging markets where veterinary CRO adoption remains dependent on available research capabilities.
Expansion of Precision Medicine and Growth of Digital Veterinary Platforms Offer Growth Opportunities to Market Players
The increasing adoption of precision medicine in animal healthcare creates opportunities for veterinary CROs to support biomarker discovery, genetic analysis, and personalized treatment studies. CROs with advanced laboratory capabilities and data analytics platforms can help pharmaceutical companies develop targeted therapies for companion animals and livestock. This opportunity is expected to expand as veterinary medicine moves toward more personalized and data-driven treatment approaches.
The rising use of digital health tools, wearable devices, and remote monitoring systems creates opportunities for veterinary CROs to support decentralized trials and real-world evidence generation. Companies offering data management, clinical analytics, and digital trial solutions can help animal health companies improve research efficiency and reduce study timelines. For example, Mars Veterinary Health leverages its global veterinary network and clinical data capabilities to support research initiatives. Increasing digitalization of veterinary care is expected to create new service opportunities for CRO providers.
Difficulty in Recruiting Suitable Animal Study Participants and Increasing Competition from In-house Research Capabilities Challenges Market Growth
The availability of suitable animals for clinical trials remains a challenge for veterinary CROs, as studies require specific breeds, disease conditions, age groups, and controlled environments. Limited access to qualified study populations can delay trial timelines and increase operational costs. For example, rare disease studies in companion animals often struggle with patient recruitment, reducing the efficiency of clinical research programs and limiting faster expansion of veterinary CRO services.
The growing ability of large animal health companies to develop internal research capabilities creates competitive pressure for veterinary CROs. Major pharmaceutical companies are investing in dedicated laboratories, digital platforms, and research teams to retain control over critical development activities. This shift can reduce outsourcing opportunities for CRO providers and challenge their ability to secure long-term partnerships with established animal health companies.
Request Customizationto receive a tailored report.
The clinical trials segment accounted for a share of 33.74% in 2025, owing to increasing outsourcing of multi-site veterinary efficacy and safety studies, rising enrollment of companion animals in regulated field trials, and growing demand for Good Clinical Practice compliant trial execution. These services help animal health companies accelerate product validation and regulatory submissions across multiple regions.
The regulatory & consulting services segment is expected to grow at a CAGR of around 8.16% during the forecast period due to increasing demand for region-specific veterinary registration strategies, expanding support for dossier preparation across multiple jurisdictions, and growing need for lifecycle regulatory compliance. These services help manufacturers navigate evolving animal health approval requirements and reduce market entry timelines.
The companion animal segment is expected to grow at a CAGR of 8.35% during the forecast period, as increasing development of specialty therapeutics for chronic pet diseases, rising enrollment in clinical studies, and expanding demand for advanced veterinary oncology research. These factors increase outsourcing of companion animal research to specialized veterinary CROs.
The livestock segment is expected to grow at a CAGR of 8.72% during the forecast period, driven by increasing development of production-enhancing biologics and growing regulatory evaluation of feed additives and veterinary vaccines. These research activities strengthen demand for large-scale livestock-focused CRO services.
The infectious diseases segment accounted for a share of 36.19% in 2025 due to increasing research on emerging zoonotic pathogens, growing development of veterinary vaccines and antimicrobial alternatives, and rising surveillance studies for transboundary animal diseases. These activities generate consistent demand for specialized infectious disease research and clinical trial services.
The dermatology segment is expected to grow at a CAGR of 8.86% during the forecast period, driven by development of monoclonal antibodies for allergic skin disorders, rising clinical studies on chronic pruritus therapies, and expanding evaluation of novel topical dermatological formulations. These innovations create sustained demand for dermatology-focused veterinary CRO expertise.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Advanced Animal Health Research Infrastructure and Strong Outsourcing of Veterinary R&D
The North America veterinary CRO market accounted for the largest regional share of 42.08% in 2025, driven by presence of leading animal health companies, well-established veterinary research infrastructure, and increasing outsourcing of preclinical and clinical development activities. The region benefits from advanced regulatory frameworks, high companion animal healthcare expenditure, and strong collaboration between pharmaceutical companies, CROs, and academic institutions.
The US veterinary CRO market was valued at USD 429.89 million in 2025, driven by increasing investment in veterinary pharmaceutical and biologics development, growing demand for outsourced clinical trials, and expanding adoption of precision animal healthcare. According to the American Veterinary Medical Association (AVMA), the US had over 133,000 licensed veterinarians in 2025, supporting extensive veterinary clinical research and product development.
The veterinary CRO market in Canada was valued at USD 62.54 million in 2025, supported by increasing investment in animal health research, growing collaboration between veterinary universities and biotechnology companies, and rising demand for innovative livestock and companion animal therapeutics. The country's emphasis on animal welfare, food safety, and disease surveillance encourages pharmaceutical companies to outsource specialized research activities.
Asia Pacific: Fastest Growth Driven by Expanding Animal Health Industry and Rising Outsourcing of Veterinary Research
The Asia Pacific veterinary CRO market is expected to grow at a CAGR of 9.46% during the forecast period, showcasing the fastest regional growth. Growth is supported by expanding animal healthcare expenditure, increasing veterinary pharmaceutical manufacturing, and rising outsourcing of research and clinical development activities. Countries across the region are strengthening veterinary infrastructure, improving animal disease surveillance, and investing in livestock productivity and companion animal healthcare.
The China veterinary CRO market was valued at USD 65.72 million in 2025, supported by rapid expansion of the domestic animal health industry, increasing investment in veterinary biologics and vaccines, and government initiatives to strengthen livestock disease prevention. Growing R&D activities by domestic pharmaceutical companies and expanding collaborations with global animal health manufacturers are increasing demand for outsourced preclinical studies, clinical trials, and regulatory support services across the country.
The India veterinary CRO market was valued at USD 33.61 million in 2025, fueled by increasing investment in veterinary vaccine development, expansion of contract research capabilities, and rising demand for affordable animal healthcare solutions. Growing livestock populations, increasing companion animal ownership, and expanding pharmaceutical manufacturing are encouraging companies to outsource research and regulatory activities. The country's skilled scientific workforce and cost-efficient research ecosystem continue to support veterinary CRO market growth.
The Japan veterinary CRO market was valued at USD 38.78 million in 2025, driven by increasing research on companion animal therapeutics, the rising development of advanced veterinary biologics, and strong regulatory standards for animal health products. The country's mature veterinary healthcare system, high pet ownership, and emphasis on innovative therapies encourage pharmaceutical companies to partner with CROs for specialized clinical research, safety evaluation, and regulatory consulting services.
Unlock Regional Insightsto access country-level data, & regional trends.
The veterinary CRO market competitive landscape is moderately fragmented, with participation from global contract research organizations, specialized animal health research providers, and technology-enabled clinical trial service companies. Established players compete through broad geographic presence, regulatory expertise, and extensive veterinary trial networks. Emerging players compete by offering expertise, digital trial platforms, flexible engagement models, and data driven research solutions. The veterinary CRO market ecosystem is shaped by the ability to provide efficient clinical trial management, advanced analytics capabilities, and cost-effective outsourcing solutions for animal health companies.
April 2026: Charles River Laboratories launched its Rat In Vitro Fertility Services, expanding its reproductive biology and embryology portfolio to support preclinical research and accelerate drug development programs.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Pavan Warade is a Research Analyst with over 4 years of expertise in Technology and Aerospace & Defense markets. He delivers detailed market assessments, technology adoption studies, and strategic forecasts. Pavan’s work enables stakeholders to capitalize on innovation and stay competitive in high-tech and defense-related industries.
We are featured on:
sales@straitsresearch.com